ClearPoint Neuro (CLPT) Depreciation and Depletion (2018 - 2019)

ClearPoint Neuro (CLPT) reported Depreciation and Depletion of $35710.0 for Q3 2019, up 38.48% on a YoY basis from $25788.0 in Q3 2018, and up 2.15% sequentially from $34960.0 in Q2 2019.

ClearPoint Neuro (CLPT) Depreciation and Depletion (2018 - 2019) Analysis & Trends

ClearPoint Neuro (CLPT) has 2 years of Depreciation and Depletion data on file, last reported at $35710.0 in Q3 2019.

  • For the quarter ending Q3 2019, Depreciation and Depletion rose 38.48% year-over-year to $35710.0; the trailing twelve-month figure through Sep 2019 stood at $131098.0 (changed N/A YoY), and the FY2025 full-year result was $400000.0, up 100.0% from the prior year.
  • Depreciation and Depletion climbed to $35710.0 in Q3 2019, from $34960.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $35710.0 in Q3 2019 to a low of $23795.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 183.75 Bn 176.46 Bn 6.27 Bn 381.00 Mn
2 Stryker 129.05 Bn 126.17 Bn 3.81 Bn 120.00 Mn
3 Medtronic 108.57 Bn 99.35 Bn 6.41 Bn 308.00 Mn
4 Boston Scientific 68.61 Bn 67.16 Bn 3.61 Bn 89.00 Mn
5 Edwards Lifesciences 48.41 Bn 44.74 Bn 1.29 Bn -
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.12 Bn 25.83 Bn 1.98 Bn 78.00 Mn
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 24.26 Bn 21.14 Bn 2.07 Bn -
10 ClearPoint Neuro 428.13 Mn 392.54 Mn 7.76 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 35,710.00
Sep 30, 2019 35,710.00
Jun 30, 2019 34,960.00
Jun 30, 2019 34,960.00
Mar 31, 2019 34,640.00
Mar 31, 2019 34,640.00
Sep 30, 2018 25,788.00
Sep 30, 2018 25,788.00
Jun 30, 2018 23,795.00
Jun 30, 2018 23,795.00
Mar 31, 2018 31,623.00
Mar 31, 2018 31,623.00